nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—prostate cancer—testicular cancer	0.918	1	CtDrD
Estradiol valerate/Dienogest—CYP3A4—Ifosfamide—testicular cancer	0.0132	0.428	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Vinblastine—testicular cancer	0.00702	0.227	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Etoposide—testicular cancer	0.00632	0.205	CbGbCtD
Estradiol valerate/Dienogest—CYP3A4—Doxorubicin—testicular cancer	0.00431	0.14	CbGbCtD
Estradiol valerate/Dienogest—Visual impairment—Ifosfamide—testicular cancer	0.000237	0.00468	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Epirubicin—testicular cancer	0.000237	0.00468	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Cisplatin—testicular cancer	0.000233	0.0046	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Ifosfamide—testicular cancer	0.000233	0.0046	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Chlorambucil—testicular cancer	0.000233	0.0046	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Methotrexate—testicular cancer	0.000232	0.00458	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Methotrexate—testicular cancer	0.000232	0.00458	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Cisplatin—testicular cancer	0.000232	0.00458	CcSEcCtD
Estradiol valerate/Dienogest—Breast pain—Doxorubicin—testicular cancer	0.00023	0.00454	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Ifosfamide—testicular cancer	0.00023	0.00454	CcSEcCtD
Estradiol valerate/Dienogest—Jaundice cholestatic—Doxorubicin—testicular cancer	0.000229	0.00451	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Ifosfamide—testicular cancer	0.000229	0.00451	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000228	0.00451	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Chlorambucil—testicular cancer	0.000228	0.0045	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Chlorambucil—testicular cancer	0.000226	0.00446	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Ifosfamide—testicular cancer	0.000222	0.00439	CcSEcCtD
Estradiol valerate/Dienogest—Hypocalcaemia—Doxorubicin—testicular cancer	0.000219	0.00433	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Methotrexate—testicular cancer	0.000219	0.00432	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Epirubicin—testicular cancer	0.000217	0.00429	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Epirubicin—testicular cancer	0.000217	0.00429	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000216	0.00427	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Ifosfamide—testicular cancer	0.000216	0.00426	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Ifosfamide—testicular cancer	0.000214	0.00423	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Etoposide—testicular cancer	0.000214	0.00422	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Etoposide—testicular cancer	0.000212	0.00419	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Chlorambucil—testicular cancer	0.00021	0.00415	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Chlorambucil—testicular cancer	0.000209	0.00413	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Cisplatin—testicular cancer	0.000209	0.00412	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Vinblastine—testicular cancer	0.000207	0.00409	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Epirubicin—testicular cancer	0.000205	0.00405	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Bleomycin—testicular cancer	0.000205	0.00404	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Bleomycin—testicular cancer	0.000205	0.00404	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Cisplatin—testicular cancer	0.000205	0.00404	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Doxorubicin—testicular cancer	0.000201	0.00397	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Doxorubicin—testicular cancer	0.000201	0.00397	CcSEcCtD
Estradiol valerate/Dienogest—Cramps of lower extremities—Epirubicin—testicular cancer	0.000199	0.00394	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Cisplatin—testicular cancer	0.000198	0.00392	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Vinblastine—testicular cancer	0.000198	0.00391	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Cisplatin—testicular cancer	0.000197	0.00389	CcSEcCtD
Estradiol valerate/Dienogest—Angioedema—Ifosfamide—testicular cancer	0.000196	0.00387	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Chlorambucil—testicular cancer	0.000195	0.00385	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Methotrexate—testicular cancer	0.000195	0.00384	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Cisplatin—testicular cancer	0.000192	0.00378	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Vinblastine—testicular cancer	0.000192	0.00378	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Dactinomycin—testicular cancer	0.000191	0.00377	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Chlorambucil—testicular cancer	0.00019	0.00375	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Doxorubicin—testicular cancer	0.00019	0.00374	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Ifosfamide—testicular cancer	0.000189	0.00374	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Chlorambucil—testicular cancer	0.000187	0.00369	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Cisplatin—testicular cancer	0.000185	0.00365	CcSEcCtD
Estradiol valerate/Dienogest—Cramps of lower extremities—Doxorubicin—testicular cancer	0.000185	0.00364	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Etoposide—testicular cancer	0.000184	0.00363	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Cisplatin—testicular cancer	0.000182	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Epirubicin—testicular cancer	0.000182	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Etoposide—testicular cancer	0.000182	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Etoposide—testicular cancer	0.00018	0.00356	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Vinblastine—testicular cancer	0.000179	0.00352	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Methotrexate—testicular cancer	0.000178	0.00351	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Cisplatin—testicular cancer	0.000178	0.00351	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Etoposide—testicular cancer	0.000176	0.00347	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Bleomycin—testicular cancer	0.000175	0.00346	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Ifosfamide—testicular cancer	0.000175	0.00345	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Ifosfamide—testicular cancer	0.000175	0.00345	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Vinblastine—testicular cancer	0.000174	0.00343	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Methotrexate—testicular cancer	0.000172	0.00339	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Ifosfamide—testicular cancer	0.000172	0.00339	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Doxorubicin—testicular cancer	0.000168	0.00332	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Chlorambucil—testicular cancer	0.000168	0.00332	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Dactinomycin—testicular cancer	0.000165	0.00325	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Epirubicin—testicular cancer	0.000163	0.00323	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Dactinomycin—testicular cancer	0.000163	0.00322	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Etoposide—testicular cancer	0.000163	0.00321	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Bleomycin—testicular cancer	0.000163	0.00321	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Epirubicin—testicular cancer	0.000161	0.00317	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Methotrexate—testicular cancer	0.000161	0.00317	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Vinblastine—testicular cancer	0.00016	0.00316	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Methotrexate—testicular cancer	0.00016	0.00315	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Chlorambucil—testicular cancer	0.000157	0.0031	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Cisplatin—testicular cancer	0.000157	0.00309	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000156	0.00308	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Epirubicin—testicular cancer	0.000155	0.00306	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Vinblastine—testicular cancer	0.000154	0.00304	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Methotrexate—testicular cancer	0.000152	0.003	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Vinblastine—testicular cancer	0.000152	0.003	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Doxorubicin—testicular cancer	0.000151	0.00299	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Dactinomycin—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Ifosfamide—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Cisplatin—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Cisplatin—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Bleomycin—testicular cancer	0.000151	0.00298	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Ifosfamide—testicular cancer	0.00015	0.00295	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Epirubicin—testicular cancer	0.000149	0.00295	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000149	0.00294	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Cisplatin—testicular cancer	0.000148	0.00292	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Bleomycin—testicular cancer	0.000147	0.0029	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Methotrexate—testicular cancer	0.000146	0.00287	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Bleomycin—testicular cancer	0.000145	0.00286	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Vinblastine—testicular cancer	0.000144	0.00284	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Doxorubicin—testicular cancer	0.000144	0.00283	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000143	0.00282	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Methotrexate—testicular cancer	0.000143	0.00282	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Epirubicin—testicular cancer	0.000142	0.00281	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Dactinomycin—testicular cancer	0.000141	0.00278	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Ifosfamide—testicular cancer	0.000139	0.00274	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Ifosfamide—testicular cancer	0.000138	0.00273	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Etoposide—testicular cancer	0.000138	0.00273	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Doxorubicin—testicular cancer	0.000138	0.00273	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Epirubicin—testicular cancer	0.000137	0.00271	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Dactinomycin—testicular cancer	0.000137	0.0027	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Epirubicin—testicular cancer	0.000136	0.00269	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Epirubicin—testicular cancer	0.000134	0.00264	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Doxorubicin—testicular cancer	0.000132	0.0026	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00013	0.00257	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Bleomycin—testicular cancer	0.00013	0.00257	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Methotrexate—testicular cancer	0.000129	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Bleomycin—testicular cancer	0.000129	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Cisplatin—testicular cancer	0.000129	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Bleomycin—testicular cancer	0.000129	0.00255	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Ifosfamide—testicular cancer	0.000129	0.00254	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Doxorubicin—testicular cancer	0.000127	0.0025	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Doxorubicin—testicular cancer	0.000126	0.00249	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Ifosfamide—testicular cancer	0.000126	0.00248	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Epirubicin—testicular cancer	0.000124	0.00245	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Ifosfamide—testicular cancer	0.000124	0.00244	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Doxorubicin—testicular cancer	0.000124	0.00244	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Epirubicin—testicular cancer	0.000123	0.00243	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Bleomycin—testicular cancer	0.000122	0.0024	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Dactinomycin—testicular cancer	0.000121	0.0024	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Dactinomycin—testicular cancer	0.00012	0.00238	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Etoposide—testicular cancer	0.000119	0.00235	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Etoposide—testicular cancer	0.000119	0.00235	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Etoposide—testicular cancer	0.000118	0.00233	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Ifosfamide—testicular cancer	0.000116	0.00228	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Doxorubicin—testicular cancer	0.000115	0.00226	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Doxorubicin—testicular cancer	0.000114	0.00225	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Dactinomycin—testicular cancer	0.000113	0.00224	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Etoposide—testicular cancer	0.000113	0.00223	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Methotrexate—testicular cancer	0.000112	0.00222	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Ifosfamide—testicular cancer	0.000111	0.0022	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Cisplatin—testicular cancer	0.000111	0.00219	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Ifosfamide—testicular cancer	0.00011	0.00218	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Ifosfamide—testicular cancer	0.00011	0.00218	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Methotrexate—testicular cancer	0.00011	0.00217	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Etoposide—testicular cancer	0.00011	0.00217	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Etoposide—testicular cancer	0.000109	0.00216	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Methotrexate—testicular cancer	0.000109	0.00215	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Cisplatin—testicular cancer	0.000108	0.00214	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Methotrexate—testicular cancer	0.000108	0.00213	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Epirubicin—testicular cancer	0.000107	0.00211	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Methotrexate—testicular cancer	0.000105	0.00208	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Epirubicin—testicular cancer	0.000105	0.00207	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Ifosfamide—testicular cancer	0.000104	0.00205	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Epirubicin—testicular cancer	0.000103	0.00203	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Methotrexate—testicular cancer	0.000102	0.00201	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Epirubicin—testicular cancer	0.000102	0.00201	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Etoposide—testicular cancer	0.000102	0.00201	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Methotrexate—testicular cancer	0.000101	0.002	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Epirubicin—testicular cancer	0.000101	0.002	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Etoposide—testicular cancer	9.91e-05	0.00196	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Doxorubicin—testicular cancer	9.91e-05	0.00196	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Epirubicin—testicular cancer	9.85e-05	0.00194	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Etoposide—testicular cancer	9.78e-05	0.00193	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Doxorubicin—testicular cancer	9.72e-05	0.00192	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Cisplatin—testicular cancer	9.59e-05	0.00189	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Epirubicin—testicular cancer	9.55e-05	0.00189	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Doxorubicin—testicular cancer	9.54e-05	0.00188	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Cisplatin—testicular cancer	9.51e-05	0.00188	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Cisplatin—testicular cancer	9.5e-05	0.00188	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Epirubicin—testicular cancer	9.49e-05	0.00187	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Doxorubicin—testicular cancer	9.43e-05	0.00186	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Doxorubicin—testicular cancer	9.36e-05	0.00185	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Epirubicin—testicular cancer	9.35e-05	0.00185	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Epirubicin—testicular cancer	9.31e-05	0.00184	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Epirubicin—testicular cancer	9.22e-05	0.00182	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Etoposide—testicular cancer	9.14e-05	0.0018	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Epirubicin—testicular cancer	9.12e-05	0.0018	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Doxorubicin—testicular cancer	9.11e-05	0.0018	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Cisplatin—testicular cancer	8.96e-05	0.00177	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Doxorubicin—testicular cancer	8.84e-05	0.00174	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Etoposide—testicular cancer	8.78e-05	0.00173	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Doxorubicin—testicular cancer	8.78e-05	0.00173	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Etoposide—testicular cancer	8.71e-05	0.00172	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Etoposide—testicular cancer	8.7e-05	0.00172	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Etoposide—testicular cancer	8.66e-05	0.00171	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Doxorubicin—testicular cancer	8.65e-05	0.00171	CcSEcCtD
Estradiol valerate/Dienogest—Tension—Doxorubicin—testicular cancer	8.62e-05	0.0017	CcSEcCtD
Estradiol valerate/Dienogest—Nervousness—Doxorubicin—testicular cancer	8.53e-05	0.00168	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Doxorubicin—testicular cancer	8.44e-05	0.00167	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Epirubicin—testicular cancer	8.39e-05	0.00166	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Methotrexate—testicular cancer	8.28e-05	0.00163	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Etoposide—testicular cancer	8.21e-05	0.00162	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Methotrexate—testicular cancer	8.12e-05	0.0016	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Epirubicin—testicular cancer	8.05e-05	0.00159	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Doxorubicin—testicular cancer	7.76e-05	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Epirubicin—testicular cancer	7.74e-05	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Epirubicin—testicular cancer	7.74e-05	0.00153	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Epirubicin—testicular cancer	7.6e-05	0.0015	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Doxorubicin—testicular cancer	7.45e-05	0.00147	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Methotrexate—testicular cancer	7.28e-05	0.00144	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Doxorubicin—testicular cancer	7.17e-05	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Doxorubicin—testicular cancer	7.17e-05	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Methotrexate—testicular cancer	7.14e-05	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Methotrexate—testicular cancer	7.14e-05	0.00141	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Methotrexate—testicular cancer	7.08e-05	0.0014	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Doxorubicin—testicular cancer	7.03e-05	0.00139	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Epirubicin—testicular cancer	6.82e-05	0.00135	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Methotrexate—testicular cancer	6.77e-05	0.00134	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Epirubicin—testicular cancer	6.69e-05	0.00132	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Epirubicin—testicular cancer	6.68e-05	0.00132	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Epirubicin—testicular cancer	6.62e-05	0.00131	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Methotrexate—testicular cancer	6.57e-05	0.0013	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Methotrexate—testicular cancer	6.54e-05	0.00129	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Epirubicin—testicular cancer	6.33e-05	0.00125	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Doxorubicin—testicular cancer	6.31e-05	0.00125	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.19e-05	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Doxorubicin—testicular cancer	6.18e-05	0.00122	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Epirubicin—testicular cancer	6.15e-05	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Doxorubicin—testicular cancer	6.13e-05	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Epirubicin—testicular cancer	6.12e-05	0.00121	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Methotrexate—testicular cancer	6.1e-05	0.0012	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Methotrexate—testicular cancer	5.94e-05	0.00117	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Doxorubicin—testicular cancer	5.86e-05	0.00116	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Methotrexate—testicular cancer	5.86e-05	0.00116	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Epirubicin—testicular cancer	5.71e-05	0.00113	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Doxorubicin—testicular cancer	5.69e-05	0.00112	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Doxorubicin—testicular cancer	5.66e-05	0.00112	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Epirubicin—testicular cancer	5.56e-05	0.0011	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Epirubicin—testicular cancer	5.48e-05	0.00108	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Methotrexate—testicular cancer	5.47e-05	0.00108	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Doxorubicin—testicular cancer	5.28e-05	0.00104	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Methotrexate—testicular cancer	5.26e-05	0.00104	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Methotrexate—testicular cancer	5.22e-05	0.00103	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Methotrexate—testicular cancer	5.21e-05	0.00103	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Methotrexate—testicular cancer	5.18e-05	0.00102	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Doxorubicin—testicular cancer	5.14e-05	0.00101	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Epirubicin—testicular cancer	5.12e-05	0.00101	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Doxorubicin—testicular cancer	5.07e-05	0.001	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Epirubicin—testicular cancer	4.92e-05	0.000972	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Methotrexate—testicular cancer	4.92e-05	0.00097	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Epirubicin—testicular cancer	4.88e-05	0.000964	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Epirubicin—testicular cancer	4.88e-05	0.000963	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Epirubicin—testicular cancer	4.85e-05	0.000958	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Doxorubicin—testicular cancer	4.74e-05	0.000935	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Epirubicin—testicular cancer	4.6e-05	0.000908	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Doxorubicin—testicular cancer	4.56e-05	0.000899	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Doxorubicin—testicular cancer	4.52e-05	0.000892	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Doxorubicin—testicular cancer	4.51e-05	0.000891	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Doxorubicin—testicular cancer	4.49e-05	0.000886	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Doxorubicin—testicular cancer	4.26e-05	0.00084	CcSEcCtD
